These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2852030)

  • 1. The association of mammary serum antigen (MSA) with the histopathological findings in localised breast cancer.
    Tjandra JJ; Busmanis I; Russell IS; Collins JP; Reed RG; McKenzie IF
    Br J Cancer; 1988 Dec; 58(6):815-7. PubMed ID: 2852030
    [No Abstract]   [Full Text] [Related]  

  • 2. Lesson of the month. The value of immunohistochemistry in breast pathology.
    Sidebotham HJ; Al-Talib RK; Theaker JM
    Histopathology; 2003 Aug; 43(2):194-5. PubMed ID: 12877736
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
    Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
    Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between the immunohistochemical expression of DF3 antigen and serum CA15-3 in breast cancer patients.
    Ohuchi N; Sato S; Akimoto M; Taira Y; Matoba N; Takahashi K; Mori S
    Jpn J Surg; 1991 Mar; 21(2):129-37. PubMed ID: 1646903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
    Sironi M; Cantaboni A
    Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.
    Sacks NP; Stacker SA; Thompson CH; Collins JP; Russell IS; Sullivan JA; McKenzie IF
    Br J Cancer; 1987 Dec; 56(6):820-4. PubMed ID: 2449238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular carcinoma in situ and intraductal carcinoma of the breast.
    Rosen PP
    Monogr Pathol; 1984; (25):59-105. PubMed ID: 6330539
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multifocal disseminated intraductal in situ carcinoma of the breast].
    Touboul E; Delafons JC; Guerin RA
    Presse Med; 1983 Jun; 12(27):1727. PubMed ID: 6308595
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of mammary serum antigen assay with mammography in patients with breast cancer.
    Hare WS; Tjandra JJ; Russell IS; Collins JP; McKenzie IF
    Med J Aust; 1988 Oct; 149(8):402-6. PubMed ID: 3050402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal breast cancer: a clinical appraisal.
    Peters TG; Donegan WL; Burg EA
    Ann Surg; 1977 Dec; 186(6):704-10. PubMed ID: 203233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
    Tupitsyn NN; Kadagidze ZG; Blokhina NG; Baryshnikov AIu; Ermilova VD; Artamonova EV; Moldenhauer G; Bernard A
    Eksp Onkol; 1990; 12(2):54-8. PubMed ID: 1690634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histopathological classification of breast cancer: a clinicopathologic analysis of 245 cases].
    Gao FX
    Zhonghua Bing Li Xue Za Zhi; 1986 Dec; 15(4):289-91. PubMed ID: 3038347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Definition and malignancy of carcinoma in situ of the mammary gland].
    Bässler R
    Verh Dtsch Ges Pathol; 1975; 59():497. PubMed ID: 175609
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunopathology of breast cancer.
    Black MM
    Pathobiol Annu; 1977; 7():213-30. PubMed ID: 201905
    [No Abstract]   [Full Text] [Related]  

  • 15. On the origin and progression of ductal carcinoma in the human breast.
    Wellings SR; Jensen HM
    J Natl Cancer Inst; 1973 May; 50(5):1111-8. PubMed ID: 4123242
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
    Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
    Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical breast cancer diagnosis].
    Schauer A; Brehler R; Bergholz M
    Verh Dtsch Ges Pathol; 1985; 69():171-86. PubMed ID: 2420086
    [No Abstract]   [Full Text] [Related]  

  • 18. The comedo subtype of intraductal carcinoma. Cytologic characteristics.
    Lilleng R; Hagmar B
    Acta Cytol; 1992; 36(3):345-52. PubMed ID: 1316029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The concept of carcinoma in situ].
    Andersen JA; Schiødt T
    Ugeskr Laeger; 1980 Mar; 142(14):867-9. PubMed ID: 6250258
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative study of mammography and mammary serum antigen estimation for breast cancer screening.
    Ward BG; Joy GJ; Ramm LE; Baker CA; McGuckin MA
    Med J Aust; 1992 Aug; 157(3):161-4. PubMed ID: 1635488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.